Immunovirotherapy with measles virus strains in combination with anti–PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment

BACKGROUND. Glioblastoma (GBM) is the most common primary malignant brain tumor and has a dismal prognosis. Measles virus (MV) therapy of GBM is a promising strategy due to preclinical efficacy, excellent clinical safety, and its ability to evoke antitumor pro-inflammatory responses. We hypothesized...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Hardcastle, Jayson, Mills, Lisa, Malo, Courtney S., Jin, Fang, Kurokawa, Cheyne, Geekiyanage, Hirosha, Schroeder, Mark, Sarkaria, Jann, Johnson, Aaron J., Galanis, Evanthia
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Basic and Translational Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464320/
https://ncbi.nlm.nih.gov/pubmed/27663389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now179
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares